Alzex Neuropharma Inc. (TRRI)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Apr 10, 2026
Alzex Neuropharma Market Cap
Alzex Neuropharma has a market cap or net worth of $753 as of April 15, 2026. Its market cap has decreased by -99.91% in one year.
Market Cap
753.00
Enterprise Value
n/a
Revenue
4.73M
Ranking
n/a
PE Ratio
0.02
Stock Price
$0.00
Market Cap Chart
Since July 14, 2008, Alzex Neuropharma's market cap has decreased from 60.00K to 753.00, a decrease of -98.75%. That is a compound annual growth rate of -21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 753.00 | 150.17% |
| Dec 30, 2025 | 301.00 | -99.90% |
| Dec 31, 2024 | 298.04K | -1.00% |
| Dec 14, 2023 | 301.05K | -9.09% |
| Dec 23, 2022 | 331.16K | -51.11% |
| Dec 28, 2021 | 677.37K | 857,331.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panbela Therapeutics | 971.00 |
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Nabriva Therapeutics | 646.00 |
| Amarantus BioScience Holdings | 630.00 |
| Virpax Pharmaceuticals | 621.00 |
| Adynxx | 581.00 |